- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03087292
Low Intensity Resistance Training With Vascular Occlusion in Coronary Heart Disease Patients
Effect of Low Intensity Resistance Training With Vascular Occlusion on Muscle Hypertrophy, Neuromuscular Adaptations and Selected Cardiovascular Parameters in Patients With Coronary Heart Disease
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Physical activity in patients with coronary heart disease improves health, quality of life, and reduces risk of coronary events, morbidity and mortality. Aerobic training is preferred as a part of cardiac rehabilitation with its well established evidence-based guidelines. On the other hand, the resistance training was first introduced as a part of cardiac rehabilitation just over a decade ago, due to its positive effects on performance, quality of life and muscle hypertrophy and strength. Despite the positive effects of resistance training, there still lacks evidence about its effect on cardiovascular health. Furthermore, guidelines still do not specify the exact training volumes, doses and types of resistance training for patients with coronary heart disease.
In clinical practice, it is often difficult and contraindicated to use near-maximal loads (e.g., in the early stages of cardiac rehabilitation, after sport injury, etc.). Muscle atrophy and weakness often occur rapidly in the affected area due to the effects of trauma (or disease) and inactivity. Consequently, training modalities that promote hypertrophy or counteract atrophy without the use of heavy loads should be of special interest in the rehabilitation of some chronic diseases for which high musculoskeletal forces are contraindicated.
Occlusive strength training with tourniquet cuffs was first used nearly twenty years ago. Studies have shown that low to-moderate intensity (20-50% of 1RM) resistance training with vascular occlusion leads to gains in muscle strength and volume comparable to those seen after conventional heavy resistance training. This effects suggest, that ischemic strength training may be a useful method in rehabilitation and other contexts.
To conclude, the aim of this study is to compare the effect of low intensity resistance training with vascular occlusion vs. normal physical activity on:
- muscle hypertrophy, strength and neuromuscular parameters;
- vascular function;
- and blood parameters (anabolic and catabolic hormones, catecholamines, inflammations factors, parameters of oxidative stress etc.)
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tim Kambič, BSc
- Phone Number: +386 (0)40830858
- Email: tim.kambic@gmail.com
Study Contact Backup
- Name: Borut Jug, PhD, MD
- Email: borut.jug@gmail.com
Study Locations
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- University Medical Centre
-
Contact:
- Borut Jug, PhD, MD
- Email: borut.jug@gmail.com
-
Contact:
- Tim Kambič, BSc
- Phone Number: +386(0)40830858
- Email: tim.kambic@gmail.com
-
Principal Investigator:
- Borut Jug, PhD, MD
-
Sub-Investigator:
- Tim Kambič, BSc
-
Sub-Investigator:
- Marko Novaković, MD
-
Sub-Investigator:
- Katja Tomažin, PhD
-
Sub-Investigator:
- Vojko Strojnik, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- above 18 years old and below 75 years old
- coronary heart disease documented with clinical event
- stable coronary heart disease patients
Exclusion Criteria:
- Unstable phase of coronary heart disease
- dysfunction of left ventricle
- residual myocardial ischemia
- contraindications for physical activity,
- intellectual development disorder,
- recent dissection of aorta
- recent vein thrombolysis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Resistance training group
Patients to be randomly assigned to the "resistance training group" will have resistance training with vascular occlusion 2 times per week for a period of 8 weeks on unilateral leg extension machine.
During each training, they will performed 3 sets of 15 repetitions at the intensity of 30% 1 RM (repetition maximum).
Each training set will separated by a 30 second rest period.
|
Patients will perform unilateral leg extension resistance training with vascular occlusion 2 times per week for a period of 8 weeks.
Each training session will consist of 3 sets of 15 repetitions at the intensity of 30% 1 RM with 30 s of rest period between sets.
|
NO_INTERVENTION: Control group
Patients to be randomly assigned to the control group (normal physical activity) will continue with their usual physical activity regime.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in maximal strength
Time Frame: 4 weeks, 8 weeks
|
Determined with one repetition maximum test on leg extension machine (kg)
|
4 weeks, 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in maximal voluntary contraction (MVC)
Time Frame: 4 and 8 weeks
|
Determined with modified interpolated twitch protocol
|
4 and 8 weeks
|
Changes of flow-mediated dilatation of the brachial artery
Time Frame: 4 weeks, 8 weeks
|
Measured with ultrasound in %
|
4 weeks, 8 weeks
|
Change in muscle hypertrophy (muscle thickness)
Time Frame: 4 and 8 weeks
|
Measured with ultrasound in mm
|
4 and 8 weeks
|
Change of the value of blood human growth hormon (HGH)
Time Frame: 4 and 8 weeks
|
measured in ng/mL
|
4 and 8 weeks
|
Change of the value of testosterone
Time Frame: 4 and 8 weeks
|
measured in ng/dL
|
4 and 8 weeks
|
Change of the value of myostatin
Time Frame: 4 and 8 weeks
|
measured in ng/mL
|
4 and 8 weeks
|
Change of the value of mechano growth factor (MGF)
Time Frame: 4 and 8 weeks
|
measured in ng/mL
|
4 and 8 weeks
|
Change of the value of insulin-like growth factor (IGF-1)
Time Frame: 4 and 8 weeks
|
measured in ng/mL
|
4 and 8 weeks
|
Change of the value of epinephrine
Time Frame: 4 and 8 weeks
|
measured in pg/mL
|
4 and 8 weeks
|
Change of the value of norepinephrine
Time Frame: 4 and 8 weeks
|
measured in pg/mL
|
4 and 8 weeks
|
Change of the value of cortisol
Time Frame: 4 and 8 weeks
|
measured in mcg/dL
|
4 and 8 weeks
|
Change in C-reactive protein
Time Frame: 4 and 8 weeks
|
measured in mg/L
|
4 and 8 weeks
|
Change in blood pressure prior and after exercise
Time Frame: 1-8 week
|
measured in mmHg
|
1-8 week
|
Change in heat-shock protein (HSP-72)
Time Frame: 4 and 8 weeks
|
measured in ng/mL
|
4 and 8 weeks
|
Change in resting and post-exercise heart rate
Time Frame: 4 and 8 weeks
|
Measured in beats per min
|
4 and 8 weeks
|
Change of from-the-questionnaire-obtained quality of life
Time Frame: 4 and 8 weeks
|
Measured in points
|
4 and 8 weeks
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Heran BS, Chen JM, Ebrahim S, Moxham T, Oldridge N, Rees K, Thompson DR, Taylor RS. Exercise-based cardiac rehabilitation for coronary heart disease. Cochrane Database Syst Rev. 2011 Jul 6;(7):CD001800. doi: 10.1002/14651858.CD001800.pub2.
- Loenneke JP, Wilson JM, Marin PJ, Zourdos MC, Bemben MG. Low intensity blood flow restriction training: a meta-analysis. Eur J Appl Physiol. 2012 May;112(5):1849-59. doi: 10.1007/s00421-011-2167-x. Epub 2011 Sep 16.
- Nakajima, T., et al. Use and safety of KAATSU training: results of a national survey. Int J KAATSU Train Res; 2(1): 5-13, 2006.
- Leon AS, Franklin BA, Costa F, Balady GJ, Berra KA, Stewart KJ, Thompson PD, Williams MA, Lauer MS; American Heart Association; Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention); Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity); American association of Cardiovascular and Pulmonary Rehabilitation. Cardiac rehabilitation and secondary prevention of coronary heart disease: an American Heart Association scientific statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity), in collaboration with the American association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005 Jan 25;111(3):369-76. doi: 10.1161/01.CIR.0000151788.08740.5C. Erratum In: Circulation. 2005 Apr 5;111(13):1717.
- Clark AM, Hartling L, Vandermeer B, McAlister FA. Meta-analysis: secondary prevention programs for patients with coronary artery disease. Ann Intern Med. 2005 Nov 1;143(9):659-72. doi: 10.7326/0003-4819-143-9-200511010-00010.
- Pollock ML, Franklin BA, Balady GJ, Chaitman BL, Fleg JL, Fletcher B, Limacher M, Pina IL, Stein RA, Williams M, Bazzarre T. AHA Science Advisory. Resistance exercise in individuals with and without cardiovascular disease: benefits, rationale, safety, and prescription: An advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology, American Heart Association; Position paper endorsed by the American College of Sports Medicine. Circulation. 2000 Feb 22;101(7):828-33. doi: 10.1161/01.cir.101.7.828. No abstract available.
- Karabulut M, Abe T, Sato Y, Bemben MG. The effects of low-intensity resistance training with vascular restriction on leg muscle strength in older men. Eur J Appl Physiol. 2010 Jan;108(1):147-55. doi: 10.1007/s00421-009-1204-5. Epub 2009 Sep 18.
- Fry CS, Glynn EL, Drummond MJ, Timmerman KL, Fujita S, Abe T, Dhanani S, Volpi E, Rasmussen BB. Blood flow restriction exercise stimulates mTORC1 signaling and muscle protein synthesis in older men. J Appl Physiol (1985). 2010 May;108(5):1199-209. doi: 10.1152/japplphysiol.01266.2009. Epub 2010 Feb 11.
- Kambic T, Novakovic M, Tomazin K, Strojnik V, Bozic-Mijovski M, Jug B. Hemodynamic and Hemostatic Response to Blood Flow Restriction Resistance Exercise in Coronary Artery Disease: A Pilot Randomized Controlled Trial. J Cardiovasc Nurs. 2021 Sep-Oct 01;36(5):507-516. doi: 10.1097/JCN.0000000000000699.
- Kambic T, Novakovic M, Tomazin K, Strojnik V, Jug B. Blood Flow Restriction Resistance Exercise Improves Muscle Strength and Hemodynamics, but Not Vascular Function in Coronary Artery Disease Patients: A Pilot Randomized Controlled Trial. Front Physiol. 2019 Jun 12;10:656. doi: 10.3389/fphys.2019.00656. eCollection 2019.
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UKCLRehab022017
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Disease
-
Elixir Medical CorporationIstituto Clinico HumanitasActive, not recruitingCoronary Artery Disease | Chronic Total Occlusion of Coronary Artery | Multi Vessel Coronary Artery Disease | Bifurcation of Coronary Artery | Long Lesions Coronary Artery DiseaseItaly
-
Fundación EPICActive, not recruitingCoronary Artery Disease | Left Main Coronary Artery Disease | Left Main Coronary Artery Stenosis | Restenosis, CoronarySpain
-
Peking Union Medical College HospitalNot yet recruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
Peking Union Medical College HospitalRecruitingCoronary Artery Disease | Inflammation | Coronary Artery Disease Progression | Coronary Artery Stenosis | Coronary Artery Restenosis | Inflammatory Disease | Inflammation VascularChina
-
IGLESIAS Juan FernandoUniversity of BernNot yet recruiting
-
National Institutes of Health Clinical Center (CC)National Heart, Lung, and Blood Institute (NHLBI)CompletedCoronary Arteriosclerosis | Coronary Artery Disease (CAD) | Obstructive Coronary Artery DiseaseUnited States
-
Barts & The London NHS TrustImperial College London; Brunel UniversityNot yet recruitingCORONARY ARTERY DISEASE
-
Fundación EPICRecruitingCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Left Main Coronary Artery Disease | Coronary Artery StenosisSpain
-
Abbott Medical DevicesCompletedCoronary Artery Disease | Coronary Disease | Coronary Occlusion | Chronic Total Occlusion of Coronary Artery | Coronary Restenosis | Coronary Artery Stenosis | Coronary Artery RestenosisBelgium
-
China National Center for Cardiovascular DiseasesRecruitingLeft Main Coronary Artery DiseaseChina
Clinical Trials on Resistance training with vascular occlusion
-
University of Sao PauloUnknown
-
University of Sao PauloUnknown
-
University of KansasCompletedBlood Flow Restriction and Low-Intensity Resistance TrainingUnited States
-
University GhentRecruitingHamstring InjuryBelgium
-
Corporacion Parc TauliInstitut de Ciències Fotòniques (ICFO); Centre de Recerca Matemàtica; Institute...RecruitingCOVID-19 | Endothelial FunctionUnited States, Spain, Brazil, Mexico
-
Riphah International UniversityCompletedCOVID-19 PandemicPakistan
-
University of Sao PauloCompletedMuscle Strength | Electric Stimulation TherapyBrazil
-
Seoul National University HospitalCompleted
-
Department of Clinical Research and InnovationCentre Hospitalier Universitaire de NiceUnknownCardiac ArrestFrance
-
Universidade Federal de PernambucoUnknownDiabetes Mellitus, Type 2Brazil